MPX-RESPONSE_HE

The MPX-RESPONSE consortium brings together a multi-disciplinary team of 16 partners coming from EU countries, Switzerland, Brazil and Argentina. It involves a broad range of expertise on infectious and viral diseases, clinical trial design, management and statistical analysis, clinical investigation for infectious diseases, health technology assessment and public health. Besides, MPX-RESPONSE engage with key external stakeholders contributing to the specification of the adaptive platform trials, including the EMA and FDA, national competent authorities, HTAs, ethics committees, health industry, and patient representatives.